3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with quipazine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carli, M; Samanin, R | 1 |
1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and quipazine
| Article | Year |
|---|---|
Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task.
Topics: Animals; Appetite Depressants; Conditioning, Operant; Fenfluramine; Haloperidol; Lysergic Acid Diethylamide; Male; Piperazines; Psychomotor Performance; Quipazine; Rats; Reaction Time; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Ritanserin; Serotonin | 1992 |